Skip to main content
. 2016 Nov 28;24(2):93–97.

Figure 2.

Figure 2.

Medicaid restrictions on reimbursement for treatment with sofosbuvir, by disease stage (A) and time since last recreational drug use (B). These maps reflect policy current in late 2015. Ongoing litigation is changing Medicaid policy on a state-by-state basis. Adapted from Barua et al.7

aRecent negotiation or litigation has resulted in Washington, Massachusetts, and Connecticut dropping all treatment restrictions.